Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roll-Out Implementation Optimization (ROIO) trial to develop and test the implementation of a food security screening and referral process: a study protocol.

Implementation science communications·2026
Same author

Cognitive function, mood and sleep changes in response to a Tai Chi/Qigong intervention among older breast cancer survivors: an exploratory analysis.

Frontiers in cognition·2026
Same author

Optimal cervical cancer screening strategies for unvaccinated and HPV-vaccinated cohorts in the United States: a comprehensive comparative modeling analysis.

Lancet regional health. Americas·2026
Same author

The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal.

Addictive behaviors reports·2026
Same author

Mirizzi Syndrome: Optimal Timing and Management.

The American surgeon·2026
Same author

The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal.

Addiction biology·2026

Related Experiment Video

Updated: Jun 9, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

TLR4 and Insulin Resistance.

Jane J Kim1, Dorothy D Sears

  • 1Department of Pediatrics, University of California, San Diego, CA 92093-0673, USA.

Gastroenterology Research and Practice
|September 4, 2010
PubMed
Summary
This summary is machine-generated.

Toll-Like Receptor 4 (TLR4) drives insulin resistance and inflammation in obesity by activating inflammatory pathways. Targeting TLR4 offers a potential therapeutic strategy for improving insulin sensitivity while maintaining immune function.

More Related Videos

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Related Experiment Videos

Last Updated: Jun 9, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Area of Science:

  • Immunology
  • Metabolic Diseases
  • Cell Biology

Background:

  • Chronic inflammation is a hallmark of insulin resistance and obesity.
  • Toll-Like Receptor 4 (TLR4) plays a crucial role in mediating innate immunity and its dysregulation contributes to metabolic dysfunction.
  • Elevated levels of both exogenous and endogenous ligands activate TLR4 in obese states.

Purpose of the Study:

  • To elucidate the role of Toll-Like Receptor 4 (TLR4) in mediating insulin resistance and inflammation.
  • To understand how TLR4 activation impairs insulin signaling pathways in target tissues.
  • To explore the therapeutic potential of targeting TLR4 for metabolic disorders.

Main Methods:

  • Investigated TLR4 expression and activation in insulin target tissues.
  • Analyzed the impact of TLR4 on inflammatory kinase activation (JNK, IKK, p38).
  • Assessed the effect of TLR4 on insulin receptor substrate (IRS) phosphorylation and gene transcription.

Main Results:

  • TLR4 activation by elevated ligands in obesity leads to the phosphorylation of JNK, IKK, and p38 kinases.
  • These kinases directly inhibit insulin signaling by phosphorylating insulin receptor substrate (IRS) on serine residues.
  • TLR4 activation increases the transcription of pro-inflammatory genes, exacerbating insulin resistance.

Conclusions:

  • TLR4 is a key mediator linking inflammation and insulin resistance in obesity.
  • Targeting TLR4 presents a promising therapeutic avenue for metabolic diseases.
  • Balancing TLR4 inhibition for metabolic benefits while preserving essential immune functions is a critical challenge.